Literature DB >> 22719158

Acute promyelocytic leukemia as a cause of intracoronary drug-eluting-stent thrombosis.

Zaven Sargsyan1, Christopher Higgins, Sanda Alexandrescu, David A Ott, Surendra K Jain.   

Abstract

Stent thrombosis is a potentially lethal complication of percutaneous coronary intervention. We describe the case of a 51-year-old man who presented with acute anterior ST-segment-elevation myocardial infarction and underwent successful percutaneous transluminal coronary angioplasty and placement of 3 drug-eluting stents in the left anterior descending coronary artery. Despite receiving dual antiplatelet therapy, the patient presented a week later with a non-ST-segment-elevation myocardial infarction and was found to have nonocclusive thrombosis of the left anterior descending coronary artery stents and his ostial left main and left circumflex coronary arteries. Subsequently, bone marrow biopsy analysis indicated that the patient had acute myelogenous leukemia, which we believe was the underlying cause of his prothrombotic state and stent thrombosis.

Entities:  

Keywords:  Coronary thrombosis/etiology/prevention & control; Mycobacterium fortuitum; hypercoagulability; hyperhomocysteinemia; leukemia, myeloid, acute; leukemia, promyelocytic; stents, drug-eluting; stents/adverse effects; stents/thrombosis

Mesh:

Substances:

Year:  2012        PMID: 22719158      PMCID: PMC3368467     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  21 in total

1.  Subacute coronary stent thrombosis in cancer patients.

Authors:  C Michael Gross; Maximilian G Posch; Christian Geier; Heike Olthoff; Jochen Krämer; Ralf Dechend; Rainer Dietz; Cemil Ozcelik
Journal:  J Am Coll Cardiol       Date:  2008-03-25       Impact factor: 24.094

2.  Intracoronary thrombus with tissue factor expression heralding acute promyelocytic leukaemia.

Authors:  Stephanie C Altwegg; Lukas A Altwegg; Willibald Maier
Journal:  Eur Heart J       Date:  2007-06-07       Impact factor: 29.983

3.  Acute promyelocytic leukemia with additional chromosomal abnormalities and absence of Auer rods.

Authors:  Z Kaleem; M S Watson; M M Zutter; M A Blinder; J L Hess
Journal:  Am J Clin Pathol       Date:  1999-07       Impact factor: 2.493

4.  Rapidly growing mycobacteria infection in patients with cancer.

Authors:  Gil Redelman-Sidi; Kent A Sepkowitz
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

5.  Native double-valve endocarditis by Mycobacterium fortuitum following percutaneous coronary intervention.

Authors:  Sathiakar Paul Collison; Naresh Trehan
Journal:  J Heart Valve Dis       Date:  2006-11

6.  Roles of protein C, protein S, and antithrombin III in acute leukemia.

Authors:  Ashish Dixit; Meganathan Kannan; M Mahapatra; Ved P Choudhry; Renu Saxena
Journal:  Am J Hematol       Date:  2006-03       Impact factor: 10.047

7.  Simultaneous subacute coronary drug-eluting stent thrombosis in two different vessels of a patient with factor V Leiden mutation.

Authors:  Parham Eshtehardi; Masoud Eslami; Davood Akhlagh Moayed
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2008-04       Impact factor: 2.160

8.  Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.

Authors:  Jochem W van Werkum; Antonius A Heestermans; A Carla Zomer; Johannes C Kelder; Maarten-Jan Suttorp; Benno J Rensing; Jacques J Koolen; B R Guus Brueren; Jan-Henk E Dambrink; Raymond W Hautvast; Freek W Verheugt; Jurriën M ten Berg
Journal:  J Am Coll Cardiol       Date:  2009-04-21       Impact factor: 24.094

9.  Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.

Authors:  Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Ivan Horvath; Matyas Keltai; Jean-Paul R Herrman; Frans Van de Werf; William E Downey; Benjamin M Scirica; Sabina A Murphy; Elliott M Antman
Journal:  Lancet       Date:  2008-04-02       Impact factor: 79.321

Review 10.  Acute myeloid leukemia associated with acute myocardial infarction and dural sinus thrombosis: the possible role of leukemia-related hyperhomocysteinemia.

Authors:  Hung Chang; Tung-Liang Lin; Wan-Jing Ho; Lung-An Hsu
Journal:  J Chin Med Assoc       Date:  2008-08       Impact factor: 2.743

View more
  3 in total

1.  Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction.

Authors:  Attila Feher; Polydoros N Kampaktsis; Rekha Parameswaran; Eytan M Stein; Richard Steingart; Dipti Gupta
Journal:  Oncologist       Date:  2017-02-03

2.  Acute myocardial/cerebral infarction as first/relapse manifestation in one acute promyelocytic leukemia patient.

Authors:  Ying Li; Shanshan Suo; Liping Mao; Lei Wang; Chunmei Yang; Weilai Xu; Yinjun Lou; Wenyuan Mai
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  New perspectives on treatment strategies for patient with acute myeloid leukemia and complex karyotype abnormalities after percutaneous coronary intervention: A case report.

Authors:  Jie Wang; Rong Chen; Xiaoqi Lin; Yubo Wang; Jian-Hua Wang; Yun Wu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.